Dipna Pharmachem [DPL] vs Sastasundar Ventures [SASTASUNDR] Detailed Stock Comparison

Dipna Pharmachem Ltd.

BSE
Loading...

Sastasundar Ventures Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Dipna Pharmachem Ltd. wins in 12 metrics, Sastasundar Ventures Ltd. wins in 6 metrics, with 0 ties. Dipna Pharmachem Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Dipna Pharmachem Ltd. Sastasundar Ventures Ltd. Better
P/E Ratio (TTM) 10.09 33.04 Dipna Pharmachem Ltd.
Price-to-Book Ratio 0.35 1.26 Dipna Pharmachem Ltd.
Debt-to-Equity Ratio 23.42 0.59 Sastasundar Ventures Ltd.
PEG Ratio N/A -0.32 N/A
EV/EBITDA 8.55 1,310.12 Dipna Pharmachem Ltd.
Profit Margin (TTM) 1.92% 2.04% Sastasundar Ventures Ltd.
Operating Margin (TTM) 2.34% 0.30% Dipna Pharmachem Ltd.
EBITDA Margin (TTM) 2.34% 0.30% Dipna Pharmachem Ltd.
Return on Equity 4.24% -10.55% Dipna Pharmachem Ltd.
Return on Assets (TTM) 1.59% -9.36% Dipna Pharmachem Ltd.
Free Cash Flow (TTM) $-92.15M $-276.65M Dipna Pharmachem Ltd.
Dividend Yield 23.16% N/A N/A
1-Year Return -67.35% 15.01% Sastasundar Ventures Ltd.
Price-to-Sales Ratio (TTM) 0.21 0.68 Dipna Pharmachem Ltd.
Enterprise Value $338.55M $10.51B Sastasundar Ventures Ltd.
EV/Revenue Ratio 0.32 0.82 Dipna Pharmachem Ltd.
Gross Profit Margin (TTM) 44.45% 7.70% Dipna Pharmachem Ltd.
Revenue per Share (TTM) $45 $401 Sastasundar Ventures Ltd.
Earnings per Share (Diluted) $0.86 $8.19 Sastasundar Ventures Ltd.
Beta (Stock Volatility) -0.17 0.37 Dipna Pharmachem Ltd.

Dipna Pharmachem Ltd. vs Sastasundar Ventures Ltd. Stock Performance Analysis

Loading Price Chart...

DPL
SASTASUNDR

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Dipna Pharmachem Ltd.-2.37%-6.80%-16.79%-13.28%-58.32%-59.48%
Sastasundar Ventures Ltd.0.00%-4.59%10.35%7.15%-2.92%1.58%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Dipna Pharmachem Ltd.-67.35%-96.95%-96.44%-90.95%-93.55%-93.55%
Sastasundar Ventures Ltd.15.01%6.44%39.03%349.85%676.86%199.03%

Performance & Financial Health Analysis: Dipna Pharmachem Ltd. vs Sastasundar Ventures Ltd.

MetricDPLSASTASUNDR
Market Information
Market Cap i₹228.19M₹8.58B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i45,90011,327
90 Day Avg. Volume i51,20013,833
Last Close₹6.99₹301.45
52 Week Range₹6.66 - ₹25.66₹252.50 - ₹363.00
% from 52W High-72.76%-16.96%
All-Time High₹558.00 (Jan 29, 2024)₹580.00 (Jan 10, 2022)
% from All-Time High-98.75%-48.03%
Growth Metrics
Quarterly Revenue Growth-0.20%0.33%
Quarterly Earnings Growth3.19%0.22%
Financial Health
Profit Margin (TTM) i0.02%0.02%
Operating Margin (TTM) i0.02%0.00%
Return on Equity (TTM) i0.04%-0.11%
Debt to Equity (MRQ) i23.420.59
Cash & Liquidity
Book Value per Share (MRQ)₹24.62₹214.21
Cash per Share (MRQ)₹0.29₹7.44
Operating Cash Flow (TTM) i₹-140,640,000₹-124,301,000
Levered Free Cash Flow (TTM) i₹-160,558,752₹-911,671,000
Dividends
Last 12-Month Dividend Yield i23.16%N/A
Last 12-Month Dividend i₹5.00₹0.00

Valuation & Enterprise Metrics Analysis: Dipna Pharmachem Ltd. vs Sastasundar Ventures Ltd.

MetricDPL (Apr 26, 2026)SASTASUNDR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i10.0933.04
Forward P/E iN/A-15.28
PEG Ratio iN/A-0.32
Price to Sales (TTM) i0.210.68
Price to Book (MRQ) i0.351.26
Market Capitalization
Market Capitalization i₹228.19M₹8.58B
Enterprise Value i₹338.55M₹10.51B
Enterprise Value Metrics
Enterprise to Revenue i0.320.82
Enterprise to EBITDA i8.551,310.12
Risk & Other Metrics
Beta i-0.170.37
Book Value per Share (MRQ) i₹24.62₹214.21

Financial Statements Comparison: Dipna Pharmachem Ltd. vs Sastasundar Ventures Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricDPL (2025)SASTASUNDR (2025)
Revenue/Sales i1.25B10.90B
Cost of Goods Sold i1.14B10.20B
COGS % of Revenue i91.0%93.6%
Gross Profit i111.90M699.73M
Gross Margin i9.0%6.4%
Research & Development iN/AN/A
Operating Income (EBIT) i40.07M-644.41M
Operating Margin i3.2%-5.9%
EBITDA i38.19M-349.77M
EBITDA Margin i3.1%-3.2%
Pre-Tax Income i14.20M-2.04B
Pre-Tax Income % of Revenue i1.1%-18.7%
Income Tax i4.47M-701.22M
Income Tax % of Revenue i0.4%-6.4%
Net Income (Profit) i9.73M-1.34B
Profit Margin i0.8%-12.3%

Balance Sheet & Liquidity Metrics

MetricDPL (2025)SASTASUNDR (2025)
Cash & Equivalents i4.26M124.22M
Total Current Assets i1.32B5.80B
Total Current Assets % of Revenue i105.9%53.2%
Total Current Liabilities i849.96M980.20M
Total Current Liabilities % of Revenue i68.0%9.0%
Long-Term Debt i88.90M6.50M
Long-Term Debt % of Revenue i7.1%0.1%
Total Shareholders Equity i384.93M8.65B
Retained Earnings i31.22M3.66B
Retained Earnings % of Revenue i2.5%33.6%
Property, Plant & Equipment i489,00099.77M

Cash Flow Statement Comparison

MetricDPL (2025)SASTASUNDR (2025)
Operating Cash Flow i-92.83M-124.30M
Operating Cash Flow % of Revenue i-7.4%-1.1%
Capital Expenditures i-201,000-100.71M
Free Cash Flow i-92.15M-276.65M
FCF Margin i-7.4%-2.5%
Debt Repayment i-36.57MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricDPLSASTASUNDR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i24.05M31.81M
Float Shares i11.37M6.23M
% Held by Insiders i51.68%80.70%
% Held by Institutions i0.00%1.15%
% Held by Public i48.32%18.15%

Dividend Analysis & Yield Comparison: Dipna Pharmachem Ltd. vs Sastasundar Ventures Ltd.

MetricDPLSASTASUNDR
Last 12-Month Dividend i₹5.00₹0.00
Last 12-Month Dividend Yield i23.16%N/A
3-Year Avg Annual Dividend i₹6.00₹0.00
3-Year Avg Dividend Yield i1.72%N/A
3-Year Total Dividends i₹18.00₹0.00
Ex-Dividend DateAug 13, 2024N/A